These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21871522)

  • 1. State of the art in benefit-risk analysis: economics and marketing-finance.
    Kalogeras N; Odekerken-Schröder G; Pennings JM; Gunnlaugsdóttir H; Holm F; Leino O; Luteijn JM; Magnússon SH; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):56-66. PubMed ID: 21871522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art in benefit-risk analysis: introduction.
    Verhagen H; Tijhuis MJ; Gunnlaugsdóttir H; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken G; Pohjola MV; Tuomisto JT; Ueland Ø; White BC; Holm F
    Food Chem Toxicol; 2012 Jan; 50(1):2-4. PubMed ID: 21679738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking beyond borders: integrating best practices in benefit-risk analysis into the field of food and nutrition.
    Tijhuis MJ; Pohjola MV; Gunnlaugsdóttir H; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken-Schröder G; Poto M; Tuomisto JT; Ueland O; White BC; Holm F; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):77-93. PubMed ID: 22142687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art in benefit-risk analysis: consumer perception.
    Ueland Ø; Gunnlaugsdottir H; Holm F; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):67-76. PubMed ID: 21683114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art in benefit-risk analysis: food and nutrition.
    Tijhuis MJ; de Jong N; Pohjola MV; Gunnlaugsdóttir H; Hendriksen M; Hoekstra J; Holm F; Kalogeras N; Leino O; van Leeuwen FX; Luteijn JM; Magnússon SH; Odekerken G; Rompelberg C; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):5-25. PubMed ID: 21679741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The paradox of overlapping micronutrient risks and benefits obligates risk/benefit analysis.
    Verkerk RH
    Toxicology; 2010 Nov; 278(1):27-38. PubMed ID: 20188138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shellfish and residual chemical contaminants: hazards, monitoring, and health risk assessment along French coasts.
    Guéguen M; Amiard JC; Arnich N; Badot PM; Claisse D; Guérin T; Vernoux JP
    Rev Environ Contam Toxicol; 2011; 213():55-111. PubMed ID: 21541848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explaining public resistance to genetically modified corn: an analysis of the distribution of benefits and risks.
    Wu F
    Risk Anal; 2004 Jun; 24(3):715-26. PubMed ID: 15209940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The United States pork niche market phenomenon.
    Honeyman MS; Pirog RS; Huber GH; Lammers PJ; Hermann JR
    J Anim Sci; 2006 Aug; 84(8):2269-75. PubMed ID: 16864889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art in benefit-risk analysis: food microbiology.
    Magnússon SH; Gunnlaugsdóttir H; Loveren Hv; Holm F; Kalogeras N; Leino O; Luteijn JM; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):33-9. PubMed ID: 21679739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and control of food safety risks: the role of governments, food producers, marketers, and academia.
    Lupien JR
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():74-9. PubMed ID: 17392080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of scientific evidence of risks and benefits in determining risk management policies for medications.
    Andrews E; Dombeck M
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art in benefit-risk analysis: medicines.
    Luteijn JM; White BC; Gunnlaugsdóttir H; Holm F; Kalogeras N; Leino O; Magnússon SH; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; McCarron PA; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):26-32. PubMed ID: 21683115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future challenges to microbial food safety.
    Havelaar AH; Brul S; de Jong A; de Jonge R; Zwietering MH; Ter Kuile BH
    Int J Food Microbiol; 2010 May; 139 Suppl 1():S79-94. PubMed ID: 19913933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.